Lupus clinical trials in Iowa
6 studies for Lupus are looking for participants at sites in Iowa.
Cities in Iowa
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, Iowa City
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Sep 15, 2026 · NCT06916806A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Iowa, Iowa City
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Sep 10, 2026 · NCT07085104A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50319, Iowa City
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 4, 2026 · NCT06617325A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- University of Iowa, Iowa City
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Aug 28, 2026 · NCT06925542Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Univeristy of Iowa, Iowa City
Recruiting
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07180537A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- University of Iowa, Iowa City
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jun 5, 2026 · NCT06613360From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.